PCMDS:A New 18 F-FET PET/MR Based Tumor Resection Plan Improved the Prognosis of Glioblastoma Patients. A Multicenter Validated Study
Research · 31.05.2026
DOI: 10.34133/research.1335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research, online erschienen am 31.05.2026. Verfasst von Ye Cheng und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Xuanwu Hospital, Capital Medical University and China International Neuroscience Institute, Beijing 100053, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Glioblastoma, IDH-wild-type, is a highly invasive tumor, and prognosis largely depends on the extent of resection. Contrast-enhanced (CE) MRI often underestimates tumor borders, resulting in incomplete resection. Prospective multicenter evidence on positron emission tomography (PET)/magnetic resonance (MR)-guided resection planning in newly diagnosed glioblastoma remains limited. This study is the first nationwide, multicenter evaluation of 18F-fluoroethyltyrosine (FET) PET-guided glioma resection.
Methods
We conducted a multicenter, prospective cohort study to evaluate the efficacy of a novel 18F-FET PET-based surgical planning system (PET/MR cross-modal tumor delineation system [PCMDS]) in glioblastoma, IDH-wild-type resection. The study comprised 239 patients: 115 underwent 18F-FET PET-guided surgery and 124 underwent CE MRI-guided surgery. The PCMDS integrated multimodal image registration and automated metabolic segmentation to delineate surgical margins. Resection outcomes were intraoperatively validated using ultrasound, MRI, and ultramicroscopic cellular imaging.
Results
Compared with the CE MRI group, the 18F-FET PET group achieved a significantly higher gross total resection rate (91.3% versus 72.7%, P < 0.05) and improved survival outcomes (median overall survival: 19.7 versus 16.0 months, P = 0.0099; median progression-free survival: 12.5 versus 9.3 months, P = 0.0078). 18F-FET PET-defined margins extended beyond CE MRI-defined boundaries, and both histopathological analysis and single-cell RNA sequencing confirmed the presence of infiltrative tumor cells in 18F-FET PET-positive but MRI-negative regions.
Conclusion
This multicenter study demonstrates that 18F-FET PET-based surgical planning significantly increases the extent of glioblastoma, IDH-wild-type resection and prolongs patient survival. Integrating 18F-FET PET into routine surgical practice could substantially improve clinical outcomes for patients with glioblastoma, IDH-wild-type.
Autor:innen und Institutionen
- Department of Neurosurgery, Xuanwu Hospital, Capital Medical University and China International Neuroscience Institute, Beijing 100053, China.
- Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University and Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing 100053, China.
- Department of Neurosurgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science & Technology, Wuhan 430030, China.
- College of Future Technology, Peking University, Beijing 100871, China.
- Department of Neurosurgery, Huashan Hospital Fudan University, Shanghai 200040, China.
- Department of Neurosurgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
ORCID-Profile: Xiaolong Wu
Zitieren
APA
Cheng, Y., Wu, X., Cui, B., Diao, H., Liang, X., Chen, X., Su, F., Liu, S., Shan, B., Lu, J., Dang, H., Zhong, C., Liu, W., Luan, Z., Du, Y., Tang, J., & Lu, J. (2026). PCMDS:A New 18 F-FET PET/MR Based Tumor Resection Plan Improved the Prognosis of Glioblastoma Patients. A Multicenter Validated Study. Research. https://doi.org/10.34133/research.1335
Vancouver
Cheng Y, Wu X, Cui B, Diao H, Liang X, Chen X, et al. PCMDS:A New 18 F-FET PET/MR Based Tumor Resection Plan Improved the Prognosis of Glioblastoma Patients. A Multicenter Validated Study. Research. 2026. doi:10.34133/research.1335
BibTeX
@article{Cheng2026,
author = {Cheng, Ye and Wu, Xiaolong and Cui, Bixiao and Diao, Huantong and Liang, Xiaohong and Chen, Xu and Su, Feng and Liu, Siheng and Shan, Bingyang and Lu, Junfeng and Dang, Haodan and Zhong, Chunlong and Liu, Wenhao and Luan, Zihao and Du, Yue and Tang, Jie and Lu, Jie},
title = {PCMDS:A New 18 F-FET PET/MR Based Tumor Resection Plan Improved the Prognosis of Glioblastoma Patients. A Multicenter Validated Study},
journal = {Research},
year = {2026},
doi = {10.34133/research.1335}
}
EUVIMED